483
AGC Biologics, Inc.FDA 483 - AGC Biologics, Inc. - July 12, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of AGC Biologics, Inc. in Bothell, WA, revealed significant deficiencies across three observations. The firm failed to consistently follow and maintain effective sanitization procedures, leading to fungal contamination trends. Additionally, investigations into unexplained discrepancies and batch failures were found to be incomplete, lacking definitive root causes and adequate follow-up actions.
Open in Dashboard
ID · 532e4a4a-b139-4ca7-8e67-b3ee13096e7d